PHH (Park Ha Biological Technology Company Limited) שווי עסקי להכנסות

Park Ha Biological Technology (PHH) business is subject to Chinese dietary supplement legislation and supply chain disruptions. The GURU.Markets terminal provides the EV/Sales multiple, where the value expresses the metric level. Geopolitics and trade barriers create currency risks, yet stable demand for consumer staples guarantees liquidity and the absence of cash flow gaps.
ir.parkha.cn - פילוחים אנליטיים ומדדי מפתח (PHH)

For Park Ha Biological Technology (PHH), which is scaling the distribution of wellness products in China, the efficiency of capitalizing every unit of revenue is critical. By analyzing the EV-to-sales ratio, an investor compares the total enterprise value with revenue volume, excluding the impact of debt load, which allows for the timely detection of asset overvaluation or the risk of capital impairment amid rising operating expenses.